An underground market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.
Experimental Treatment Gaining Traction Online
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are encouraged to contact these accounts directly for supplier links, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Additionally, a robust trade exists on messaging services, where communities with numerous of participants share comparison images, administration instructions and assertions of next-day UK delivery. Sellers promote the substance there before directing customers to WhatsApp for purchases.
Learning About The Experimental Drug
This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.
Medical Professionals Voice Concerns
Nevertheless, physicians and pharmacists have warned that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals injecting substances of unknown origin.
Some professionals said the popularity for the experimental drug could be linked to the rising price of approved weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved medication that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.
Some influencers try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate medicines, marketing, and customer regulations, potentially leading to fines, legal action or prison.
Service Response and Material Elimination
Based on TikTok, the service has taken down violative content and prohibited associated hashtags and query recommendations. The organization said it was committed to keeping the service secure and investing in enhancing enforcement strategies.
Online Trading Operations
Research also found groups with up to nine thousand members selling the experimental drug using the platform's integrated search feature, which functions like a online catalog. Typing “retatrutide” immediately displays channels with numerous of members, populated with photos of weight loss, positive testimonials and detailed instructions for preparing or injecting at residence.
Within moments of joining one community, a seller shared WhatsApp details, where the majority of transactions take place. The seller sent an instruction manual and promised shipping within 48 hours. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None asked about weight, health issues or previous experience.
Item Details and Pricing
Within these groups, messages display dark colored parcels with postal service stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with sterile water, or pre-filled pens typically priced at 160 pounds for 20mg. When asked how long a injector should last, sellers give conflicting responses varying between a few weeks to “depends on your body”.
Platform Moderation and Security Actions
A spokesperson for Telegram stated it actively moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are administering substances they can’t verify. Even if the research behind retatrutide is valid, these digital products may not include what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are using social media. But fake injections are extremely risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.
Her team has previously encountered patients harmed by personal administration from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company investigational substance not yet authorized … may subject users to potentially serious medical dangers”.
